Commercializing New BIDMC Technologies

The mission of the Technology Ventures Office (TVO) is to promote public utilization of Beth Israel Deaconess Medical Center (BIDMC) technologies for society's use and benefit and to foster alliances with industry through collaboration and licensing agreements, while generating unrestricted income to support research at our institution.

We work with biomedical companies, venture capitalists, and entrepreneurs to find the best way to commercialize new technologies and to promote corporate collaborations that can increase our level of industrial support for research.

From Evaluation to Royalty Distribution

TVO is comprised of a group of technically trained and business-oriented professionals that:

  • Evaluates, patents, markets, and licenses BIDMC faculty inventions.
  • Manages patent prosecution.
  • Negotiates license, option, corporate sponsored research, material transfer, and confidentiality agreements.
  • Distributes royalty income derived from technology transfer among inventors, their laboratories, their departments, Research Fund, and the Medical Center's general fund according to BIDMC policy.